Bejescin (obinutuzumab-β) - Beijing Mabworks Biotech
Gazyva (obinutuzumab) - Roche, Biogen
Obinutuzumab beta Combined with Glucocorticoids for the Treatment of ANCA-associated Glomerulonephritis: A Pilot Clinical Trial (ChiCTR) - Oct 16, 2026 - P=N/A | N=20 | Not yet recruiting | Sponsor: Peking Union Medical College Hospital; Peking Union Medical College Hospital 
New trial • Glomerulonephritis • Lupus Nephritis • Nephrology
https://www.chictr.org.cn/showproj.html?proj=334055
 
Oct 16, 2026
 
Prev Next